PCI Biotech
Business Services · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ullernchausséen 64, Oslo, Oslo, 0379, No...Phone Number
+47 67115400Website
www.pcibiotech.noRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About PCI Biotech
PCI Biotech specializes in advancing the manufacturing of viral vectors and developing technologies for intracellular drug delivery. Their focus areas include immunotherapy and dermatology, targeting clients in the biopharmaceutical industry. The company is committed to innovative solutions that enhance therapeutic efficacy. PCI Biotech actively engages in partnerships to further its research and development efforts.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PCI Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when PCI Biotech launches new products
Congratulate Masked Content for being promoted to Masked Content at PCI Biotech
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once PCI Biotech has new funding data
Check out if PCI Biotech is spiking on competitors!
PCI Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on PCI Biotech recently announced quarterly report
Check if PCI Biotech has recently received funding, and reach out quickly before it becomes old news!
Click to see if PCI Biotech had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
PCI Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PCI Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PCI Biotech.
PCI Biotech Tech Stack
A closer look at the technologies used by PCI Biotech
PCI Biotech News & Media
PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options
Oslo (Norway), 8 January 2026 – PCI Biotech (OSE: PCIB). Reference is made to the company’s latest announcement dated 23rd October 2025. The external evaluation of a new bioprocessing technology has been concluded, with no prospects for further collaboration. As PCI Biotech’s limited operations were contingent upon sustained external interest, all R&D operations will now be discontinued.PCI Biotech update
Oslo (Norway), 23 October 2025 – PCI Biotech (OSE: PCIB) today provides an update on the ongoing evaluation of its operations.PCI Biotech update on future operations
Oslo (Norway), 25 September 2025 – PCI Biotech (OSE:PCIB) today announces an update on the ongoing evaluation of its future operations.PCI Biotech half-year interim 2025 report
Oslo (Norway), 29 August 2025 – PCI Biotech (OSE: PCIB), today announces its half-yearly 2025 interim report. Please find enclosed the interim report and presentation.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PCI Biotech
Sign Up For FreeTo access detailed company insights
PCI Biotech specializes in advancing the manufacturing of viral vectors and developing technologies for intracellular drug delivery. Their focus areas include immunotherapy and dermatology, targeting clients in the biopharmaceutical industry. The company is committed to innovative solutions that enhance therapeutic efficacy. PCI Biotech actively en... Read More
